Roos E, Roossien F F
J Cell Biol. 1987 Jul;105(1):553-9. doi: 10.1083/jcb.105.1.553.
We studied the interaction of MB6A lymphoma and TAM2D2 T cell hybridoma cells with hepatocyte cultures as an in vitro model for in vivo liver invasion by these tumor cells. A monoclonal antibody against leukocyte function-associated antigen-1 (LFA-1) inhibited adhesion of the tumor cells to the surface of hepatocytes and consequently strongly reduced invasion. This effect was specific since control antibodies, directed against Thy.1 and against T200, of the same isotype, similar affinity, and comparable binding to these cells, did not inhibit adhesion. This suggests that LFA-1 is involved in the formation of liver metastases by lymphoma cells. TAM2D2 T cell hybridoma cells were agglutinated by anti-LFA-1, but not by control antibodies. Reduction of adhesion was not due to this agglutination since monovalent Fab fragments inhibited adhesion as well, inhibition was also seen under conditions where agglutination was minimal, and anti-LFA-1 similarly affected adhesion of MB6A lymphoma cells that were not agglutinated. The two cell types differed in LFA-1 surface density. TAM2D2 cells exhibited 400,000 surface LFA-1 molecules, 10 times more than MB6A cells. Nevertheless, the level of adhesion and the extent of inhibition by the anti-LFA-1 antibody were only slightly larger for the TAM2D2 cells.
我们研究了MB6A淋巴瘤细胞和TAM2D2 T细胞杂交瘤细胞与肝细胞培养物之间的相互作用,以此作为这些肿瘤细胞在体内侵袭肝脏的体外模型。一种针对白细胞功能相关抗原-1(LFA-1)的单克隆抗体抑制了肿瘤细胞与肝细胞表面的黏附,从而显著降低了侵袭能力。这种效应具有特异性,因为针对Thy.1和T200的同型对照抗体,具有相似的亲和力且与这些细胞的结合能力相当,但并未抑制黏附。这表明LFA-1参与了淋巴瘤细胞肝转移的形成。TAM2D2 T细胞杂交瘤细胞被抗LFA-1抗体凝集,但未被对照抗体凝集。黏附的降低并非由于这种凝集,因为单价Fab片段也能抑制黏附,在凝集作用最小的条件下也能观察到抑制作用,并且抗LFA-1同样影响未被凝集的MB6A淋巴瘤细胞的黏附。这两种细胞类型在LFA-1表面密度上存在差异。TAM2D2细胞表面有400,000个LFA-1分子,是MB6A细胞的10倍。然而,TAM2D2细胞的黏附水平和抗LFA-1抗体的抑制程度仅略高于MB6A细胞。